Stockreport

ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ranges of $854 million to $87 [Read more]